Eran Metzger, MD
Medical Director of Psychiatry, Hebrew SeniorLife, Boston, MA. Assistant Professor of Psychiatry, Harvard Medical School, Boston, MA.
Dr. Metzger has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Shelly L. Gray, PharmD
Professor and Plein Endowed Director, Plein Center for Geriatric Pharmacy Research, School of Pharmacy, University of Washington, Seattle, WA.
Dr. Gray has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.
Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.
Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Victoria Hendrick, MD.
Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.
Dr. Hendrick has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
